NCT03277690: A reported trial by Cortendo AB
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03277690 |
|---|---|
| Title | A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 26, 2017 |
| Completion date | June 30, 2020 |
| Required reporting date | June 30, 2023, midnight |
| Actual reporting date | April 15, 2022 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |